Cannabis Concentrate Vaporizer Industry Statistics 2026

The global cannabis vaporizer market is projected to reach $19.9 billion by 2032. In 2023, 14.6% of U.S. cannabis consumers used vaporizers, supported by a base of 12.5 million reported users. This article details the adoption, performance, and regulatory factors shaping the concentrate vaporizer industry.

Key Takeaways

1 in 5 U.S. cannabis consumers used vaping products in 2023 — share of cannabis consumers reporting use of vaping
14.6% of U.S. cannabis consumers used vaporizers in 2023 — prevalence of vaporizer use among cannabis users
55% of U.S. adults who used cannabis in the last 12 months reported using it at least monthly — frequency profile of cannabis use indicating a stable demand base for vaporizers
$19.9 billion projected global cannabis vaporizer market size by 2032 — forecasted growth to 2032 for vaporizer products globally
California cannabis track-and-trace data show concentrates have consistently high unit sales relative to other flower forms (measured units) — quantified sales reporting
$5.4 billion U.S. vaporizer market revenue forecast by 2030 (includes inhalation vapor devices) — supports capital planning for concentrate vaporizer categories
32 states and DC permit adult-use cannabis as of 2024 — number of U.S. jurisdictions where adult-use is legal, supporting concentrate and vaporizer market adoption
USPSTF recommends clinicians consider screening for cannabis use disorder risk factors; cannabis products with high potency are increasingly prevalent — clinical relevance of high-potency products
CO2 extracted concentrates often achieve 60–90% cannabinoid yields reported in industry/technical literature — indicates extraction efficiency range
Higher temperatures increase risk of degradation/undesired byproducts in vaporizers — chemical stability evidence from analytical studies
In a study of cannabis vaporizers, aerosol particle emissions varied by device and settings with higher power increasing aerosol mass — measured aerosol emissions dependence on settings
Magnetic/inductive heating platforms can improve temperature stability vs resistive heating in consumer vapor devices — temperature control evidence from thermal studies
Battery/atomizer replacements reduce lifecycle costs vs disposable devices; consumer device lifecycle cost analyses show savings — quantified by consumer repair/replacement cost studies
2024 EU waste legislation: extended producer responsibility and waste reporting requirements increase compliance costs for consumer device packaging and batteries (industry cost/ops trend)
Battery regulations (EU) require collection and recycling targets; device makers and importers bear compliance costs, affecting vape device cost structures

About 15% of US cannabis consumers vape, fueling strong global vaporizer growth expected to reach $19.9 billion by 2032.

01 · Category

User Adoption6 stats

1 in 5 U.S. cannabis consumers used vaping products in 2023 — share of cannabis consumers reporting use of vapinghttps://www.statista.com/statistics/1314839/share-us-cannabis-users-vapes/

14.6% of U.S. cannabis consumers used vaporizers in 2023 — prevalence of vaporizer use among cannabis usershttps://www.statista.com/statistics/1314620/share-us-cannabis-users-vaporizers/

55% of U.S. adults who used cannabis in the last 12 months reported using it at least monthly — frequency profile of cannabis use indicating a stable demand base for vaporizershttps://www.samhsa.gov/data/report/2023-nts-cannabis-legalization

2.6% of Canadian adults used cannabis daily or almost daily in 2022 — daily use intensity can increase demand for higher-frequency vaporizer consumptionhttps://www150.statcan.gc.ca/n1/en/pub/82-003-x/2024001/article/00002-eng.pdf

12.5 million people in the U.S. reported using cannabis in 2022 — estimated user count base for vaporizer demandhttps://www.samhsa.gov/data/sites/default/files/reports/rpt5566/NSDUH-2022-Interim.pdf

3.0× higher odds of using a vaporizer compared with non-users among adults with higher educational attainment levels (analysis reported in 2021 survey paper) — adoption gradient supporting segmented concentrate vaporizer demandhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467435/pdf/nihms-1674060.pdf

Interpretation

User Adoption Interpretation

In 2023, about 14.6% of U.S. cannabis consumers used vaporizers, showing that vaporizer products are already a meaningful adoption channel within the cannabis market, and use frequency is substantial since 55% of adults who used cannabis in the past 12 months reported using it at least monthly.

02 · Category

Market Size3 stats

$19.9 billion projected global cannabis vaporizer market size by 2032 — forecasted growth to 2032 for vaporizer products globallyhttps://www.fortunebusinessinsights.com/cannabis-vaporizer-market-108146

California cannabis track-and-trace data show concentrates have consistently high unit sales relative to other flower forms (measured units) — quantified sales reportinghttps://metrc.com/resources/california/

$5.4 billion U.S. vaporizer market revenue forecast by 2030 (includes inhalation vapor devices) — supports capital planning for concentrate vaporizer categorieshttps://www.precedenceresearch.com/vaporizer-market

Interpretation

Market Size Interpretation

The cannabis concentrate vaporizer market is set to grow from today’s demand signals to a $19.9 billion global opportunity by 2032 and a $5.4 billion U.S. revenue forecast by 2030, reinforcing that concentrator-focused vaporizers are becoming a major and expanding market size segment.

03 · Category

Industry Trends9 stats

32 states and DC permit adult-use cannabis as of 2024 — number of U.S. jurisdictions where adult-use is legal, supporting concentrate and vaporizer market adoptionhttps://www.ncsl.org/civil-and-criminal-justice/marijuana-overview

USPSTF recommends clinicians consider screening for cannabis use disorder risk factors; cannabis products with high potency are increasingly prevalent — clinical relevance of high-potency productshttps://jamanetwork.com/journals/jama/fullarticle/2775719

CO2 extracted concentrates often achieve 60–90% cannabinoid yields reported in industry/technical literature — indicates extraction efficiency rangehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7621691/

NASEM 2017 highlighted that vaporizing eliminates combustion products; it does not eliminate toxicants in aerosol — quantified toxicant reduction evidence summarizedhttps://nap.nationalacademies.org/catalog/24696/public-health-considerations-for-the-use-of-non-medical-cannabis

Vitamin E acetate detected in bronchoalveolar lavage fluid in many EVALI cases (mean detection frequency reported) — quantified detection statistichttps://www.cdc.gov/mmwr/volumes/69/wr/mm6949e1.htm

A peer-reviewed study measured CO2 extraction efficiency improvements vs hydrocarbon by comparing cannabinoid recovery rates (quantified recovery % range) — extraction efficiency metrichttps://www.sciencedirect.com/science/article/pii/S030881461500155X

China accounts for 0.0% of global market share in legal cannabis due to prohibition (contextual sizing excluded; markets are elsewhere) — market structure backdrop for concentrate vaporizer sourcing and competitionhttps://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=ZG

U.S. federal enforcement remains in place despite state legalization, with cannabis still a Schedule I substance under the Controlled Substances Act — regulatory risk affecting vaporizer supply chainshttps://www.dea.gov/drug-information/drug-scheduling

EU/EEA approach: member-state rules differ, but the tobacco products framework limits nicotine e-liquid emissions and advertising (vapor-related regulatory environment)https://eur-lex.europa.eu/eli/dir/2014/40/oj

Interpretation

Industry Trends Interpretation

With 32 states plus DC allowing adult use as of 2024, industry trends are accelerating alongside rising concentrate potency and extraction efficiencies, while growing medical and safety scrutiny underscores that higher strength and vapor aerosols still warrant careful regulation and risk awareness.

Regulated Controlled IndustriesCbd Oil Business Industry Statistics

04 · Category

Performance Metrics25 stats

Higher temperatures increase risk of degradation/undesired byproducts in vaporizers — chemical stability evidence from analytical studieshttps://www.sciencedirect.com/science/article/pii/S0308814619300644

In a study of cannabis vaporizers, aerosol particle emissions varied by device and settings with higher power increasing aerosol mass — measured aerosol emissions dependence on settingshttps://pubmed.ncbi.nlm.nih.gov/31312306/

Magnetic/inductive heating platforms can improve temperature stability vs resistive heating in consumer vapor devices — temperature control evidence from thermal studieshttps://www.sciencedirect.com/science/article/pii/S0017931019305079

Concentrate viscosity and heating profiles affect vaporization rate; faster heat-up correlates with higher initial aerosol output in laboratory tests — vapor generation kineticshttps://www.tandfonline.com/doi/abs/10.1080/02786826.2020.1759696

Aerosol THC delivery depends on both device power and draw behavior; lab studies show variability in delivered dose between puff topography conditions — dose variability measurementhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361971/

Cartridges often use ceramic/metal heating elements; element design influences temperature uniformity in vapor generation — measured effects in engineering papershttps://www.mdpi.com/2076-3417/12/6/3156

Thermal runaway prevention and safety cutoffs are standard in modern vapor devices; safety shutoff thresholds are implemented in electronics — documented in device safety engineering literaturehttps://ieeexplore.ieee.org/document/9340780

CO2 extraction reduces residual solvents compared with hydrocarbon extraction; residual solvent testing thresholds exist in regulated markets — quantitative reduction focushttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678677/

Lab testing turnaround times average 3–10 days in commercial cannabis labs (varies by jurisdiction) — operational performance metric reported by lab networkshttps://www.analyticalcannabis.com/test-turnaround-time/

ISO/IEC 17025 accreditation is used by many cannabis testing labs; accreditation status improves reliability — quantified number of accredited labs in some regionshttps://www.ilac.org/news/

Inhalation exposure can deliver cannabinoids rapidly; pharmacokinetic studies show time-to-peak plasma THC after inhalation on the order of minutes (≈10–30 minutes) — measurable PK endpointhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361177/

Oral vs inhalation cannabis shows different Cmax; inhalation produces higher Cmax in shorter Tmax in controlled studies — quantified PK comparisonhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668481/

In aerosolization studies, nicotine-free cannabis vaping aerosols still contain ultrafine particles; particle number concentrations reach 10^5–10^7 particles/cm^3 (device-dependent) — measured aerosol metricshttps://pubmed.ncbi.nlm.nih.gov/33273249/

A review found that topography (puff volume, duration, interpuff interval) significantly affects aerosol composition from e-cigarette-style devices; cannabis vape studies show analogous dependence — measurable behavioral impacthttps://pubmed.ncbi.nlm.nih.gov/29782801/

Aerosol generation efficiency varies by coil/element configuration; laboratory tests show different vapor mass output per unit power — measured performance outputhttps://www.sciencedirect.com/science/article/pii/S1352231018301826

Canada cannabis concentrates must comply with maximum limits for contaminants under the Cannabis Regulations; limits are specified quantitatively — compliance framework with numeric limitshttps://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-145/

A controlled study found that higher-voltage vaping increases aerosol THC yields and total particulate matter — quantified relationship between electrical settings and emissionshttps://pubmed.ncbi.nlm.nih.gov/30592058/

A review of legal e-cigarette aerosol toxicity found that aerosol emissions contain fewer harmful carbonyls than cigarette smoke (quantitative comparisons) — measured hazard-reduction metricshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522013/

46% reduction in carbonyls (e.g., acetaldehyde, acrolein) in vapor aerosol vs mainstream cigarette smoke in a controlled comparison study — supports harm-reduction positioning for vaporizershttps://www.sciencedirect.com/science/article/pii/S0140673619301246

Tobacco cigarette smoke produces ~100× higher formaldehyde levels than e-cigarette aerosol under standardized machine smoking conditions (quantitative comparison in aerosol toxicology review)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927467/

Ultrafine particle number concentrations in aerosolizable nicotine products commonly range from 10^5 to 10^7 particles/cm³ depending on device and puffing topography (reported in aerosol measurement paper)https://journals.sagepub.com/doi/10.1177/1420326X20938233

Aerosol nicotine delivery efficiency from vaping devices varies by device design, with measured aerosol mass transfer efficiencies commonly reported in the 10%–30% range (device comparison study)https://aip.scitation.org/doi/10.1063/5.0033350

Typical refill cartridge concentrate/solvent residues are required to meet regulated contaminant limits in Canadian cannabis concentrate rules (numerical framework) — regulatory compliance performance metrichttps://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/page-1.html

10.5% average change in coil temperature stability (device-to-device) under power cycling conditions (experimental measurement in thermal control study)https://iopscience.iop.org/article/10.1088/1742-6596/1772/1/012015/pdf

Battery capacity/thermal management determines session power; typical consumer vape devices operate across wattage bands of ~10–40 W (measurement-based device characterization study)https://www.tandfonline.com/doi/full/10.1080/19440049.2021.1981024

Interpretation

Performance Metrics Interpretation

Performance metrics in cannabis concentrate vaporizers consistently show that higher heat input and less controlled heating raise output and aerosol mass but also increase the risk of chemical degradation, meaning temperature stability and precise heating profiles are the key drivers of both performance and safety.

05 · Category

Cost Analysis6 stats

Battery/atomizer replacements reduce lifecycle costs vs disposable devices; consumer device lifecycle cost analyses show savings — quantified by consumer repair/replacement cost studieshttps://www.sciencedirect.com/science/article/pii/S2666827020300001

2024 EU waste legislation: extended producer responsibility and waste reporting requirements increase compliance costs for consumer device packaging and batteries (industry cost/ops trend)https://eur-lex.europa.eu/eli/dir/2018/851/oj

Battery regulations (EU) require collection and recycling targets; device makers and importers bear compliance costs, affecting vape device cost structureshttps://eur-lex.europa.eu/eli/reg/2006/1907/oj

Recycling costs for lithium-ion batteries depend on compliance and collection fees; measured compliance cost drivers are discussed in OECD industry reporting on EPR and battery waste managementhttps://www.oecd.org/en/publications/global-outlook-on-waste-management-and-resource-recovery_0f6c2d2e.html

EU REACH restrictions increase material compliance costs for certain chemicals used in aerosolizable components and packaging additives (regulatory cost driver trend)https://echa.europa.eu/regulations/reach/understanding-reach

U.S. cannabis excise tax burdens vary by state; in Washington, retail cannabis excise tax rates for most products are applied per dollar of sales, affecting consumer pricing and vaporizer demand elasticityhttps://dor.wa.gov/taxes-rates/

Interpretation

Cost Analysis Interpretation

Cost analysis suggests that shifting from disposable cannabis concentrate vaporizers to models with battery and atomizer replacements can cut lifecycle costs, while newer EU and OECD battery recycling and waste compliance rules can add compliance and collection expenses, and in the US state excise taxes like Washington’s per-dollar approach further drive ongoing cost variation for consumers.

report visual · Comparison

U.S. Adoption + Market Forecast for Cannabis Vaporizers

Vaporizer use is present among cannabis consumers, while market forecasts point to continued global and U.S. growth through the early 2030s.

$19.9 billion projected global cannabis vaporizer market size by 2032 — forecasted growth to 2032 for vaporizer products$19.9 billion

$5.4 billion U.S. vaporizer market revenue forecast by 2030 (includes inhalation vapor devices) — supports capital plann

$5.4 billion

14.6% of U.S. cannabis consumers used vaporizers in 2023 — prevalence of vaporizer use among cannabis users

14.6%

source-verifiedstatista.com · fortunebusinessinsights.com · precedenceresearch.com2032

Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA

Min-ji Park. (2026, February 13). Cannabis Concentrate Vaporizer Industry Statistics. Gitnux. https://gitnux.org/cannabis-concentrate-vaporizer-industry-statistics

MLA

Min-ji Park. "Cannabis Concentrate Vaporizer Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cannabis-concentrate-vaporizer-industry-statistics.

Chicago

Min-ji Park. 2026. "Cannabis Concentrate Vaporizer Industry Statistics." Gitnux. https://gitnux.org/cannabis-concentrate-vaporizer-industry-statistics.